123 results
Page 2 of 7
8-K
EX-99.1
q0ym5hw6x0yo6m xyt
10 Jan 22
Regulation FD Disclosure
6:02am
8-K
EX-99
iwkj8be0f19lntz
21 Dec 21
Hepion Pharmaceuticals Announces FDA Clearance of IND Application for CRV431 in the Treatment of Liver Cancer
8:25am
8-K
EX-99.1
5btsa
13 Jul 21
Hepion Pharmaceuticals Announces Positive Topline Data from Phase 2a ‘AMBITION’ NASH Trial; All Primary Endpoints Achieved
10:38am
8-K
EX-1.1
jdv5g9xixo
17 Feb 21
Hepion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
8:06am
424B5
adzrpfhg3bmcl
16 Feb 21
Prospectus supplement for primary offering
5:11pm